Form 4: Glen Taylor Reports Changes in Beneficial Ownership of Envoy Medical, Inc. (COCH)

Sentiment:

SEC Form 4 Filing


Glen Taylor, a director and 10% owner of Envoy Medical, Inc., filed a Form 4 detailing changes in his beneficial ownership, including the acquisition of warrants.

Summary

  • Glen Taylor, a director and 10% owner of Envoy Medical, Inc. (COCH), filed a Form 4 with the SEC.
  • The report details changes in beneficial ownership of Envoy Medical's Class A Common Stock and derivative securities.
  • Taylor directly owns 2,953,607 shares of Class A Common Stock.
  • Taylor indirectly owns 2,526,058 shares of Class A Common Stock through Taylor Sports Group and 4,810,384 shares through GAT Funding, LLC.
  • A warrant to purchase 250,000 shares of Class A Common Stock at $3.04 was acquired on May 23, 2024, as a commitment fee related to a promissory note draw.
  • GAT Funding, LLC also holds warrants to purchase 500,000 shares at $1.24 and Series A Preferred Stock convertible into 869,565 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Related Party Transactions

  • The warrant issued to GAT Funding, LLC is related to a promissory note draw, indicating a financial relationship between the company and an entity controlled by Glen Taylor.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding insider ownership.
  • The acquisition of warrants by a significant shareholder could be viewed positively, indicating confidence in the company's future.

Key Dates

DateDescription
02/27/2024Date of warrant exercisable and expiration for 500,000 shares at $1.24 held by GAT Funding, LLC.
05/23/2024Date of transaction for the acquisition of a warrant to purchase 250,000 shares at $3.04.
05/24/2024Reference to the Issuer's 8-K filing with the SEC regarding the promissory note and warrant issuance.
05/28/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.